| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 02/08/2007 | WO2007016563A2 Alcohol resistant pharmaceutical formulations |
| 02/08/2007 | WO2007016545A2 Porous materials having multi-size geometries |
| 02/08/2007 | WO2007016410A2 High viscosity antibacterials |
| 02/08/2007 | WO2007016394A1 Adherent and erodible film to treat a moist surface of a body tissue |
| 02/08/2007 | WO2007016388A2 Liquid formulations for controlled delivery of benzisoxazole derivatives |
| 02/08/2007 | WO2007016371A2 Readily shapeable xerogels having controllably delayed swelling properties |
| 02/08/2007 | WO2007016287A2 Pdt treatment method for cellulites and cosmetic use |
| 02/08/2007 | WO2007016146A2 Method for retarding systemic delivery rate for easily absorbable active agents |
| 02/08/2007 | WO2007016128A2 Magnesium salt proton pump inhibitor dosage forms |
| 02/08/2007 | WO2007016073A1 Pharmaceutical emulsion compositions comprising cyclosporin |
| 02/08/2007 | WO2007015668A1 New salt iii |
| 02/08/2007 | WO2007015667A1 New salt ii |
| 02/08/2007 | WO2007015666A1 New salt i |
| 02/08/2007 | WO2007015510A1 Method for prevention of degradation of thermally unstable substance |
| 02/08/2007 | WO2007015453A1 Lotion preparation containing pyridonecarboxylic acid derivative |
| 02/08/2007 | WO2007015441A1 Adjuvant or pharmaceutical preparation for transdermal or transmucosal administration |
| 02/08/2007 | WO2007015270A2 Novel controlled release compositions of selective serotonin reuptake inhibitors |
| 02/08/2007 | WO2007015171A2 Method of treating patients with a mucinous glycoprotein (muc-1) vaccine |
| 02/08/2007 | WO2007014928A1 Pharmaceutical composition comprising granular pantoprazole |
| 02/08/2007 | WO2007014755A1 Method of producing nano- and microcapsules of spider silk protein |
| 02/08/2007 | WO2007014754A1 Process for the preparation of liposomal formulations |
| 02/08/2007 | WO2007014748A1 Method of preserving a customised composition |
| 02/08/2007 | WO2007014563A2 Anhydrous multiphase gel system |
| 02/08/2007 | WO2007014515A1 Use of hydroxybenzoic acid ester and analogues for the manufacture of a mendicament for the prevention and treatment of virus infection |
| 02/08/2007 | WO2007014514A1 Use of p-hydroxybenzoic acid and analogues for the manufacture of a mendicament for the prevention and treatment of skin mucosa virus infection |
| 02/08/2007 | WO2007014497A1 A composition comprising silver nanoparticles and the use thereof |
| 02/08/2007 | WO2007014476A1 Pharmaceutical composition containing indometacin and/or acemetacin |
| 02/08/2007 | WO2007014445A1 Microdevices comprising nanocapsules for controlled delivery of drugs and method of manufacturing same |
| 02/08/2007 | WO2006129161A3 Vitamin formulation |
| 02/08/2007 | WO2006128471A3 A solid pharmaceutical composition with a first fraction of a dispersion medium and a second fraction of a matrix, the latter being at least partially first exposed to gastrointestinal fluids |
| 02/08/2007 | WO2006127905A3 Portable drug delivery device |
| 02/08/2007 | WO2006127096A3 Cyclooxygenase inhibitor and calcium channel antagonist compositions and methods for use in urological procedures |
| 02/08/2007 | WO2006116392A3 Particle-containing complex porous materials |
| 02/08/2007 | WO2006109175A3 Solid dosage form of an antidiabetic drug |
| 02/08/2007 | WO2006099864A3 Pellet-type controlled-release preparation containing cinnarizine and dimenhydrinate for combating vertigo |
| 02/08/2007 | WO2006099514A9 Drug delivery compositions and related methods |
| 02/08/2007 | WO2006096439A3 Pharmaceutical compositions for the treatment and/or prevention of schizophrenia and related diseases |
| 02/08/2007 | WO2006091529A3 A solid pharmaceutical dosage formulation |
| 02/08/2007 | WO2006089674A3 Tablets with improved drug substance dispersibility |
| 02/08/2007 | WO2006086775A3 Methods and compositions for reducing systemic toxicity of vectors |
| 02/08/2007 | WO2006085227A3 Microcapsules and emulsions containing low bloom gelatin and methods of making and using thereof |
| 02/08/2007 | WO2006081208A3 Medical devices containing crazed polymeric release regions for drug delivery |
| 02/08/2007 | WO2006077494A3 A process for preparing solid dosage forms for extended-release of biguanide and sulfonylurea |
| 02/08/2007 | WO2006074204A3 Topical stabilized prostaglandin e compound dosage forms |
| 02/08/2007 | WO2006062980A3 Stable non-crystalline formulation comprising tiagabine |
| 02/08/2007 | WO2006050301A3 Dye-free pharmaceutical suspensions and related methods |
| 02/08/2007 | WO2006015944A3 Extended release tablet formulation containing pramipexole or a pharmaceutically acceptable salt thereof |
| 02/08/2007 | WO2006015943A3 Extended release pellet formulation containing pramipexole or a pharmaceutically acceptable salt thereof, method for manufacturing the same and use thereof |
| 02/08/2007 | WO2005107728A3 Use of targeted oxidative therapeutic formulation in treatment of diabetes and obesity |
| 02/08/2007 | US20070032572 Films with optical clarity, wear resistance and superior performance with nanofillers and polymers for thin films |
| 02/08/2007 | US20070032471 Active substance combination comprising a 2,5-dihydroxybenzenesulfonic compound and a potassium ion channel modulator |
| 02/08/2007 | US20070031887 Aqueous-based pharmaceutical composition |
| 02/08/2007 | US20070031505 Methods for fabricating nano and microparticles for drug delivery |
| 02/08/2007 | US20070031504 Microdevices comprising nanocapsules for controlled delivery of drugs and method of manufacturing same |
| 02/08/2007 | US20070031503 Hyaluronic acid modification products and drug carrier therefrom |
| 02/08/2007 | US20070031502 Pharmaceutical composition for the treatment of acute disorders |
| 02/08/2007 | US20070031501 Use of recombinant or synthetic gelatin-like proteins as stabiliser in lyophilized pharmaceutical compositions |
| 02/08/2007 | US20070031500 Long-acting solid formulation comprising triptorelin acetate |
| 02/08/2007 | US20070031499 Readily shapeable xerogels having controllably delayed swelling properties |
| 02/08/2007 | US20070031498 Gel composition for cellular adhesion inhibition |
| 02/08/2007 | US20070031497 Gastric acid secretion inhibiting composition |
| 02/08/2007 | US20070031496 Osmotic dosage forms comprising semipermeable membranes with polymer blends providing improved properties |
| 02/08/2007 | US20070031495 Permeant delivery system and methods for use thereof |
| 02/08/2007 | US20070031494 Method of administering a partial dose using a segmented pharmaceutical tablet |
| 02/08/2007 | US20070031493 Pharmaceutical compositions |
| 02/08/2007 | US20070031492 Remote controlled synthesis system |
| 02/08/2007 | US20070031491 Bioadhesive progressive hydration tablets |
| 02/08/2007 | US20070031490 Effervescent powders for inhalation |
| 02/08/2007 | US20070031489 administering sub-analgesic dosage of a mu -opioid agonist selected from morphine, fentanyl, sufentanil, alfentanil, oxymorphone and hydromorphone, or salt, and a sub-analgesic dosage of oxycodone, a kappa 2-opioid agonist to prevent sleep apnea while treating pain |
| 02/08/2007 | US20070031488 Method of administering a partial dose of a segmented pharmaceutical tablet |
| 02/08/2007 | US20070031487 Vitamin A, vitamin B1, vitamin B2, vitamin B6, vitamin B12, folic acid, vitamin D3, vitamin C, vitamin E, niacin, copper, magnesium, zinc, and iron |
| 02/08/2007 | US20070031485 Pharmaceutical composition having a cationic excipient |
| 02/08/2007 | US20070031484 Immunoliposomes that optimize internationalization into target cells |
| 02/08/2007 | US20070031483 Aggregates with increased deformability, comprising at least three amphipats, for improved transport through semi-permeable barriers and for the non-invasive drug application in vivo, especially through the skin |
| 02/08/2007 | US20070031482 PDT treatment method for cellulites and cosmetic use |
| 02/08/2007 | US20070031481 Phospolipid derivative |
| 02/08/2007 | US20070031480 Enhanced delivery of sphingolipids |
| 02/08/2007 | US20070031479 Bioadhesive gel based on hydroxyethycellulose |
| 02/08/2007 | US20070031477 Methods and devices for holding a composition |
| 02/08/2007 | US20070031463 Methods and devices for releasing volatile substances |
| 02/08/2007 | US20070031460 micelles; cyclosporin A solubilized via fatty acid and/or fatty alcohol |
| 02/08/2007 | US20070031459 Oral suspension of prednisolone acetate |
| 02/08/2007 | US20070031458 Recombinant Vibrio cholerae strain and vaccine comprising said strain |
| 02/08/2007 | US20070031388 Cell-charged multi-layer collagen membrane |
| 02/08/2007 | US20070031349 Rapidly absorbing oral formulations of PDE 5 inhibitors |
| 02/08/2007 | US20070031347 Powdered Medicaments Containing A Tiotropium Salt and Salmeterol Xinafoate |
| 02/08/2007 | US20070031346 use in sclerotherapy of blood vessels; from a device, injecting a mixture of blood dispersible gases carbon dioxide and/or oxygen, and a sclerosing agent polidocanol, foaming in blood veins; avoiding use of potentially hazardous amounts of nitrogen; treating varicose veins disorder; drug delivery device |
| 02/08/2007 | US20070031345 Generation of therapeutic microfoam |
| 02/08/2007 | US20070031344 Aerosolized anti-infectives, anti-inflammatories, and decongestants for the treatment of sinusitis |
| 02/08/2007 | US20070031340 Aerosols; vaporization |
| 02/08/2007 | US20070029185 Apparatus for producing nanoparticles |
| 02/08/2007 | DE10260882B4 Dosieraerosole mit Sojalecithin als oberflächenaktiver Substanz und dessen Verwendung MDIs containing soy lecithin as a surfactant and its use |
| 02/08/2007 | DE102005035986A1 Steriles tropfbares mehrphasiges emulgatorfreies ophthalmisches Präparat Sterile, droppable multiphase emulsifier-free ophthalmic preparation |
| 02/08/2007 | CA2620451A1 Anhydrous multiphase gel system |
| 02/08/2007 | CA2617406A1 New salt iii |
| 02/08/2007 | CA2617404A1 New salt ii |
| 02/08/2007 | CA2617403A1 New salt i |
| 02/08/2007 | CA2617286A1 Pharmaceutical formulations comprising a long-acting beta2-agonist for administration by nebulisation |
| 02/08/2007 | CA2617164A1 Alcohol resistant pharmaceutical formulations |
| 02/08/2007 | CA2616845A1 Modified release tablet formulations with enhanced mechanical properties |